(Q44431125)

English

Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir

scientific article published on May 1, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Koen van Besien

12

object named as

van Besien K

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Chen YH

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A. Verma

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

S. Devine

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

M. Morrow

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

Y-H Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

M. Mihalov

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

D. Peace

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

W. Stock

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

K. Pursell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

A. Wickrema

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

M. Yassine

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

E. Jessop

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732890

30 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://www.nature.com/articles/1703916.pdf

Portable Document Format

1 reference

10.1038/SJ.BMT.1703916

https://api.crossref.org/works/10.1038/SJ.BMT.1703916

30 December 2023

https://www.nature.com/articles/1703916

1 reference

10.1038/SJ.BMT.1703916

https://api.crossref.org/works/10.1038/SJ.BMT.1703916

30 December 2023

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

813-816

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Prevention and Treatment of Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

21 January 2018

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus disease occurring before engraftment in marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703916

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703916

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44431125&oldid=2206640735"